Google
ANIP 株価分析 — Ani Pharmaceuticals Inc (Healthcare >> Drug Manufacturers - Specialty & Generic)
ANIP に関するよくある質問
ANIPのPER（株価収益率）は？
Ani Pharmaceuticals Inc（ANIP）は現在PER 20.09倍で取引されています。
ANIPのROE（自己資本利益率）は？
Ani Pharmaceuticals IncのROEは15.95%です。
ANIPの配当利回りは？
Ani Pharmaceuticals Incの配当利回りは0.00%です。
ANIPの品質スコア（Quality Score）は？
当社のAIはANIPの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ANIPは今が買い時ですか？
当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ANIPはどのセクターに属しますか？
Ani Pharmaceuticals IncはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます（NASDAQ市場）
ANIP AI Analysis Summary
Our AI summary for ANIP: Ani Pharmaceuticals Inc (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 20.09, ROE of 15.95%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 80.06
Price
0.82
(1.03%)
Day Change
|
|
|---|
ANIP, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | In "Invest - GROWTH" Section |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1436
|
| Magic Formula Rank by ROE |
1436
|
| Magic Formula Rank by ROIC |
1229
|
| Price | 80.06 |
| PBV / Sector |
3.20 / 9.54
|
| Earning Per Share | 3.98 |
| PE / Sector |
20.09 / 28.71
|
| PEG or PE/Growth / Sector |
-0.07 / -0.10
|
| Average 1M Daily Value |
20.92 M
GREAT
|
| Average 1W Daily Value |
21.17 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-04 08:01:09 |
| Symbol | ANIP |
| Name | ANI PHARMACEUTICALS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 22.73 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,801.49 / 10,605.93 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 210 Main Street West, Baudette, MN, United States, 56623
Phone: 218 634 3500
Website: https://www.anipharmaceuticals.com
Employees: 970
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
